This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Comparative Study

JULIO V. RIVERA, M.D.

Arch Intern Med. 1961;108(4):512-518.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The desirability of treatment of gout with agents which control hyperuricemia and reduce the metabolic pool of uric acid in the body by producing uric acid diuresis is well established. This form of treatment results in control of joint manifestations, reduction in size of tophi, and, in some cases, in improvement of renal manifestations.¹ Salicylates,² probenecid,^3-5 cortisone analogues, phenylbutazone,⁶ and sulfinpyrazone⁷ have been used to this end. All these agents act similarly by inhibiting the renal tubular mechanism which is responsible for the reabsorption of uric acid filtered by the glomeruli.^8,9

Recently, zoxazolamine, an agent originally introduced as a muscle relaxant, has been found to possess a potent uricosuric action.^10,11 This drug is particularly interesting because of its chemical dissimilarity to the agents previously used. Burns et al.¹¹ have reported studies on the metabolic fate of this drug and its effect on . . . [Full Text PDF of this Article]

Author Affiliations
SAN JUAN, PUERTO RICO

From the Medical Service and the Medical Research Laboratory, San Patricio Veterans Administration Hospital and the School of Medicine, School of Tropical Medicine, University of Puerto Rico, San Juan, Puerto Rico.

Footnotes
Submitted for publication June 8, 1960.

With the technical assistance of José M. León, B.S.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?